Archives
-
EGCG Nanoparticles Boost FLASH Radiotherapy
2026-08-21
A 2026 International Journal of Nanomedicine study reports that functionalized, self-assembled epigallocatechin gallate nanoparticles, termed BENPs, can intensify FLASH radiotherapy-induced oxidative stress and tumor injury while stimulating antitumor immune responses. The work connects radiosensitization with immune remodeling and provides a framework for combining DNA damage measurements, tumor efficacy, and systemic safety assessment.
-
Fulvestrant: From ER Biology to Translation
2026-08-20
Fulvestrant (ICI 182,780) offers more than ER blockade: it enables translational researchers to connect ERα degradation, MDM2 protein turnover, chemotherapy sensitization, and endocrine therapy resistance research while defining the limits of cross-domain inference.
-
Firefly Luciferase mRNA: 5-moUTP and Cap1 Design
2026-08-20
Firefly Luciferase mRNA R1013 is a Cap1-capped, 5-moUTP modified mRNA for transient luciferase expression and bioluminescent reporter assays. Its defined 1921-nucleotide transcript, approximately 100-nucleotide poly(A) tail, and 1 mg/mL formulation support standardized mRNA delivery and translation efficiency assay workflows.
-
CTDNEP1–NEP1R1 Control of ER Lipid Fate
2026-08-19
A 2024 Molecular Biology of the Cell study shows that CTDNEP1 depends on NEP1R1 for stability and control of ER membrane expansion, but not for its role in limiting lipid droplet biogenesis. By combining structure–function analysis, cellular depletion systems, protein biochemistry, and quantitative imaging, the work reveals that one phosphatase can be differentially regulated according to whether cells are producing membrane or storing neutral lipid.
-
(S)-(+)-Methoprene: Assay Workflows
2026-08-19
Build reproducible insect endocrine assays with a stereochemically defined juvenile hormone analog that connects Met signaling to developmental and reproductive phenotypes. This guide combines dosing logic, miRNA–mRNA assay design, practical controls, and troubleshooting for applied arthropod research.
-
Ionizable Lipid Design for Organ-Selective mRNA LNPs
2026-08-18
The reference study applies the Ugi four-component reaction to rapidly generate structurally diverse ionizable lipids for mRNA lipid nanoparticles. Its screening results show that lipid skeletons, functional-group arrangement, and even constitutional isomerism can alter delivery potency and shift expression from the liver toward the spleen.
-
Praeruptorin A: From Fe²⁺ Screening to Mechanism
2026-08-18
Praeruptorin A is an angular pyranocoumarin compound with evidence spanning DMT1-mediated ferroptosis, inflammation, intestinal barrier injury, and tumor-cell invasion. This article translates the key Fe²⁺-screening study into a practical, endpoint-driven framework for cardiomyopathy research and related preclinical assays.
-
Alosetron in Intestinal Stem Cell Research
2026-08-17
Alosetron offers a practical pharmacology layer for testing how 5-HT3 signaling intersects with intestinal epithelial polarity, stem-cell fate, and barrier behavior. This guide translates CDC42–YAP–EGF–mTOR findings into controlled organoid and monolayer workflows, with concentration design, controls, readouts, and troubleshooting guidance.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-17
Pair Cy5 fluorescence with firefly luciferase to distinguish where an mRNA travels from how efficiently it is translated. This practical workflow uses dual readouts to optimize delivery systems, compare lipoplexes, and troubleshoot expression in cell and animal studies.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-16
The 2025 reference study developed a streptavidin–biotin-DNA tracking platform with high-throughput imaging to distinguish LNP uptake from productive intracellular trafficking. Its results indicate that elevated cholesterol promotes aggregation of LNP-containing peripheral early endosomes, restricting endolysosomal progression and reducing nucleic acid delivery.
-
Ibuprofen Workflows for Colon Cancer Research
2026-08-15
Use Ibuprofen as a controlled COX perturbation and a practical probe for proliferation, apoptosis, and cell-cycle phenotypes. This workflow pairs solubility management with orthogonal cellular assays and a protein-binding perspective to improve interpretation in translational cancer research.
-
High-Throughput Discovery of M. tuberculosis DHFR Inhibitors
2026-08-14
Santa Maria and colleagues developed a framework that combines phenotypic antibacterial screening, affinity-based target profiling, and machine learning to connect bioactive compounds with likely efficacy targets. Applied retrospectively and prospectively, the strategy recovered known antibacterial mechanisms and identified nanomolar Mycobacterium tuberculosis dihydrofolate reductase inhibitors with modeled selectivity over human cells.
-
IAM LC and LEKC for Pulmonary Drug Permeability
2026-08-14
This reference study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. Across 26 drug-like molecules, LEKC more closely reflected apparent lung permeability, whereas IAM LC offered broader analyte coverage, simpler operation, and stronger suitability for high-throughput screening.
-
PEG-Lipids and LNP Performance From In Vitro to In Vivo
2026-08-13
Borah and colleagues show that PEG-lipid acyl-chain length can strongly influence mRNA lipid nanoparticle performance, even when the PEG-lipid represents only a small fraction of the formulation. Across HeLa assays and mouse intramuscular, subcutaneous, and intravenous studies, DMG-PEG 2000 produced greater expression than DSG-PEG 2000, providing a practical rationale for treating PEG-lipid selection as a primary formulation variable rather than a minor stabilizer choice.
-
Olaparib (AZD2281): Mechanism and Research Use
2026-08-13
Olaparib, also called AZD2281, is a selective PARP1/2 inhibitor used to study DNA damage response and homologous recombination deficiency. Its strongest research rationale is synthetic lethality in BRCA1- or BRCA2-deficient models, while nanoparticle and hydrogel studies support preclinical investigation of localized delivery.